vaccines-gynecologic-oncology-2018-posters

Page 80

Journal of Clinical Immunology and Allergy

ISSN: 2471-304X

E u r o p e a n C o n g r e s s o n

Vaccines & Vaccination

and Gynecologic Oncology

Vaccines & Vaccination and Gynecologic Oncology 2018

O c t o b e r 2 6 - 2 7 , 2 0 1 8

B u d a p e s t , H u n g a r y

he reviewof the factors hindering access to vaccination and the process of accompanying the actors as part of the plan for strength-

ening social mobilization and communication capacities to remove barriers to access to vaccination for all. The main measures

taken are: 1) the commitment of the program and district management teams to assume their functions; 2) Upgrading vaccinating

agents to acquire the necessary knowledge, skills and attitudes that encourage the vaccination of targets by trust; 3) the promotion of

good practices towards change, reason for the program through the opportunities to communicate differently and to share data in favor

of vaccination: Involvement of the press, distribution of SMS by telephone operators, alliance with Religious, promotion of vaccination

in schools so that students are vectors of good information on vaccination in their family, social networks, publication of a bulletin on

vaccination, involvement of artists and promoters of culture, incentives/ promotion, action research development, on-going systemic

data analysis, advisory support, integrated supervision, program review, local funding for immunization.

Study of factors limiting universal access and

use immunization services in the African context

Alpha Ahmadou Diallo

, Peter G

, F Biro Diallo

and Mahi Barry

1,2,3,4

University Conakry, Guinea

Journal of Clinical Immunology and Allergy, Volume: 4

DOI: 10.21767/2471-304X-C2-006

Euro Vaccines 2018